News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • YETI shares traded near $43.58 after an investor day outlining growth targets.
  • Direct-to-consumer sales identified as the primary driver of near-term revenue growth.
  • Management flagged international expansion as a key lever for market share gains.
  • Company presented a framework for margin expansion focused on DTC channels.
  • Valuation implies an enterprise value around $3.16 billion and an implied P/E near 18.
  • Analysts recommended a tactical long position in YETI to capture momentum.

Latest Articles

BofA Reports Surge in Financials Inflows as Q2 Earnings Season Begins

BofA Reports Surge in Financials Inflows as Q2 Earnings Season Begins

Bank of America clients increased allocations to U.S. equities for a second consecutive week, driven by heavy institutional buying. Single-stock purchases reached $5.1 billion - the third-largest weekly total since 2008 - while equity ETFs attracted $1.8 billion. Financials posted the largest sector-level single-stock inflows in more than a decade …

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

VivoSim Labs, Inc. reported receiving a $5 million milestone payment from Eli Lilly linked to the advancement of a drug acquired from VivoSim's inflammatory bowel disease program. The company projects over 500% revenue growth in fiscal year 2027 driven by strong customer adoption of its innovative NAM-based 3D human cellular models for preclinical …

Kratos Opens New 167,000-Square-Foot Manufacturing Facility in Pennsylvania, Expanding Existing Footprint in the State

Kratos Opens New 167,000-Square-Foot Manufacturing Facility in Pennsylvania, Expanding Existing Footprint in the State

Kratos Defense & Security Solutions has opened a new 167,000-square-foot manufacturing facility in York, Pennsylvania, expanding its existing operations to support critical national security programs including hypersonic systems, missile defense, radar, and counter-unmanned aircraft systems. The company plans to invest over $7 million in new manufa…

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

aTyr Pharma announced subgroup analysis from their Phase 3 EFZO-FIT study showing clinically meaningful improvements in lung function and multiple patient-reported outcomes in pulmonary sarcoidosis patients with restrictive lung disease treated with 5.0 mg/kg efzofitimod. The company submitted a protocol to the FDA for a targeted Phase 3 study focu…

Greenland Mines Reports 36–44% PdEq Grade Uplift and +31% Increase in Indicated PdEq Ounces at its Skaergaard Gold, Palladium, Platinum Project in First S-K 1300 Technical Report Summary

Greenland Mines Reports 36–44% PdEq Grade Uplift and +31% Increase in Indicated PdEq Ounces at its Skaergaard Gold, Palladium, Platinum Project in First S-K 1300 Technical Report Summary

Greenland Mines Ltd announced a substantial upgrade to its Skaergaard precious and critical metals project mineral resource estimate under the SEC's new S-K 1300 reporting standards. The updated 2026 Mineral Resource Estimate shows a 31% increase in indicated PdEq ounces and a 36% uplift in grade compared to the 2022 baseline, supported by improved…

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

MediciNova, Inc. announced reaching the target enrollment of 200 patients in the NIH-funded SEANOBI-ALS study assessing their investigational drug MN-166 (ibudilast) for amyotrophic lateral sclerosis (ALS). The Expanded Access Program provides treatment to patients ineligible for other trials, marking a significant milestone in patient engagement. …

Sunrun Announces Date for Second Quarter 2026 Earnings Report

Sunrun Announces Date for Second Quarter 2026 Earnings Report

Sunrun Inc., a leading US provider of home solar and battery storage solutions, announced that it will release its second quarter 2026 earnings report after market close on August 5, 2026, followed by a conference call to discuss the results. The company offers home energy systems with a no-upfront-cost subscription model and contributes to grid st…

Anthony Petrazzuoli Joins Provident Bank as Senior Vice President, Deposit & Payments Operations Director

Anthony Petrazzuoli Joins Provident Bank as Senior Vice President, Deposit & Payments Operations Director

Provident Bank has announced the hiring of Anthony Petrazzuoli as Senior Vice President, Deposit & Payments Operations Director. Bringing over 25 years of banking experience, Petrazzuoli will oversee deposit and payment operations to enhance customer experience, regulatory compliance, and strategic initiatives supporting the bank's growth. His prio…

Top KingWin Ltd. Announces Trading Ticker Symbol Change to “DPU”

Top KingWin Ltd. Announces Trading Ticker Symbol Change to “DPU”

Top KingWin Ltd., a Cayman Islands holding company operating in China and the U.S., announced that effective July 16, 2026, its Class A ordinary shares will trade under the new ticker symbol 'DPU' on the Nasdaq Capital Market, replacing the previous symbol 'WAI'. No shareholder action is required, and the CUSIP number remains unchanged. The company…

AFC Commits $7 Million to a Senior Credit Facility

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) has committed $7 million to a $25 million senior secured credit facility aimed at refinancing existing capital and supporting growth through acquisitions in a leading outpatient behavioral health platform. The credit facility has a four-year term, is secured by all assets of the borrower, and demonstrates…

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

Rani Therapeutics announced positive initial results from its Phase 1a clinical trial of RT-114, an orally administered GLP-1/GLP-2 dual agonist for obesity treatment delivered via their RaniPill® Capsule. The oral dose achieved over 150% systemic exposure compared to a matched subcutaneous injection, with no serious adverse events and mild treatme…